9 Meters Biopharma, Inc. (NMTR) stock falls in Pre-Market: Why is it so?
9 Meters Biopharma, Inc. (NASDAQ: NMTR), a clinical-stage biopharmaceutical company specializing in treatments for rare diseases with unmet medical attention. , announced that the Company’s Chief Executive Officer, John Temperato will report a corporate update at Oppenheimer’s Rare & Orphan Disease Summit. NMTR stock price declined adjacent to the news. At last check-in premarket trading, […]
Is This The Reason The NMTR Stock Increased By Almost 11%?
With over 13.78 million 9 Meters Biopharma Inc. (NASDAQ: NMTR) shares trading Wednesday and a closing price of $1.23 on the day, the market cap was approximately 308.20 million. The NMTR stock has shown a negative weekly performance of -9.56% whereas its price on 04/07/21 gained nearly 10.81%. Currently, there are 216.07M common shares of […]
